KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Depreciation & Amortization - Total (2022 - 2025)

Pacific Biosciences Of California has reported Depreciation & Amortization - Total over the past 4 years, most recently at $2.7 million for Q4 2025.

  • Quarterly results put Depreciation & Amortization - Total at $2.7 million for Q4 2025, down 3.27% from a year ago — trailing twelve months through Dec 2025 was $13.0 million (down 5.62% YoY), and the annual figure for FY2025 was $13.0 million, down 5.62%.
  • Depreciation & Amortization - Total for Q4 2025 was $2.7 million at Pacific Biosciences Of California, up from $2.5 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization - Total for PACB hit a ceiling of $5.1 million in Q1 2025 and a floor of $2.3 million in Q1 2022.
  • Median Depreciation & Amortization - Total over the past 4 years was $2.8 million (2023), compared with a mean of $3.0 million.
  • Peak annual rise in Depreciation & Amortization - Total hit 58.36% in 2025, while the deepest fall reached 41.31% in 2025.
  • Pacific Biosciences Of California's Depreciation & Amortization - Total stood at $2.5 million in 2022, then grew by 18.48% to $3.0 million in 2023, then decreased by 5.68% to $2.8 million in 2024, then decreased by 3.27% to $2.7 million in 2025.
  • The last three reported values for Depreciation & Amortization - Total were $2.7 million (Q4 2025), $2.5 million (Q3 2025), and $2.7 million (Q2 2025) per Business Quant data.